These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 16344312)

  • 1. Gemcitabine doublets in advanced pancreatic cancer: should we move on?
    Rocha Lima CM; Flores AM
    J Clin Oncol; 2006 Jan; 24(3):327-9. PubMed ID: 16344312
    [No Abstract]   [Full Text] [Related]  

  • 2. Gemcitabine plus cisplatin in advanced pancreatic cancer.
    McWilliams RR; Alberts SR
    J Clin Oncol; 2007 Mar; 25(9):1142; author reply 1142-3. PubMed ID: 17369580
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer.
    Heinemann V; Quietzsch D; Gieseler F; Gonnermann M; Schönekäs H; Rost A; Neuhaus H; Haag C; Clemens M; Heinrich B; Vehling-Kaiser U; Fuchs M; Fleckenstein D; Gesierich W; Uthgenannt D; Einsele H; Holstege A; Hinke A; Schalhorn A; Wilkowski R
    J Clin Oncol; 2006 Aug; 24(24):3946-52. PubMed ID: 16921047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemoradiation for pancreatic adenocarcinoma].
    Flandin I; Mornex F; Claude L; Kubas A; Khodri M; Wautot V; Mazeron R; Partensky C
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S80-7. PubMed ID: 15679252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capecitabine in carcinoma of the pancreas.
    Smith DB; Neoptolemos JP
    Expert Opin Pharmacother; 2006 Aug; 7(12):1633-9. PubMed ID: 16872266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gemcitabine and pancreatic cancer].
    Prost P; Ychou M; Azria D
    Bull Cancer; 2002 Aug; 89 Spec No():S91-5. PubMed ID: 12449037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-line therapy in gemcitabine-pretreated patients with advanced pancreatic cancer.
    Boeck S; Heinemann V
    J Clin Oncol; 2008 Mar; 26(7):1178-9; author reply 1179. PubMed ID: 18309957
    [No Abstract]   [Full Text] [Related]  

  • 8. [Efficacy of gemcitabine-based chemotherapy on advanced pancreatic cancer].
    Gong JF; Zhang XD; Li J; Di LJ; Jin ML; Shen L
    Ai Zheng; 2007 Aug; 26(8):890-4. PubMed ID: 17697554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral capecitabine therapy: experience and developments at the Milano Cancer Institute].
    Longo F; Mansueto G
    Tumori; 2004; 90(1):suppl 17-27. PubMed ID: 15143996
    [No Abstract]   [Full Text] [Related]  

  • 10. Gemcitabine: progress in the treatment of pancreatic cancer.
    Heinemann V
    Oncology; 2001; 60(1):8-18. PubMed ID: 11150902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic chemotherapy with gemcitabine for advanced biliary tract carcinoma].
    Nakamura N; Teramoto K; Arii S
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():534-8. PubMed ID: 16457320
    [No Abstract]   [Full Text] [Related]  

  • 12. Gemcitabine and platinum combinations in pancreatic cancer.
    Philip PA
    Cancer; 2002 Aug; 95(4 Suppl):908-11. PubMed ID: 12209670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pancreatic carcinoma: progress in therapy].
    Lordick F
    Krankenpfl J; 2004; 42(5-6):158-9. PubMed ID: 15527223
    [No Abstract]   [Full Text] [Related]  

  • 14. Gemcitabine mono-therapy versus gemcitabine plus targeted therapy in advanced pancreatic cancer: a meta-analysis of randomized phase III trials.
    Ottaiano A; Capozzi M; De Divitiis C; De Stefano A; Botti G; Avallone A; Tafuto S
    Acta Oncol; 2017 Mar; 56(3):377-383. PubMed ID: 28256961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of randomized trials: evaluation of benefit of gemcitabine-based molecular targeted therapy for inoperable pancreatic cancer.
    Cao Y; Wu L; Tan A; Liu L; Liao C; Gao F
    Pancreas; 2010 Mar; 39(2):253-5. PubMed ID: 20182311
    [No Abstract]   [Full Text] [Related]  

  • 16. [Gemcitabine: Applications and perspectives].
    Tumori; 1997; 83(5):877-80. PubMed ID: 9446252
    [No Abstract]   [Full Text] [Related]  

  • 17. Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison.
    Sultana A; Ghaneh P; Cunningham D; Starling N; Neoptolemos JP; Smith CT
    BMC Cancer; 2008 Jul; 8():192. PubMed ID: 18611273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Locally advanced unresectable pancreatic cancer: Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial].
    Barhoumi M; Mornex F; Bonnetain F; Rougier P; Mariette C; Bouché O; Bosset JF; Aparicio T; Mineur L; Azzedine A; Hammel P; Butel J; Stremsdoerfer N; Maingon P; Bedenne L; Chauffert B
    Cancer Radiother; 2011 Jun; 15(3):182-91. PubMed ID: 21315644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conventional chemotherapy of advanced pancreatic cancer.
    Giuliani F; Di Maio M; Colucci G; Perrone F
    Curr Drug Targets; 2012 Jun; 13(6):795-801. PubMed ID: 22458526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial.
    Reni M; Cordio S; Milandri C; Passoni P; Bonetto E; Oliani C; Luppi G; Nicoletti R; Galli L; Bordonaro R; Passardi A; Zerbi A; Balzano G; Aldrighetti L; Staudacher C; Villa E; Di Carlo V
    Lancet Oncol; 2005 Jun; 6(6):369-76. PubMed ID: 15925814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.